| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.19 | 0.02 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.02 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |